Editorial Comment

Suzette E Sutherland^{1

2}

Affiliations

¹ Female Urology, UW Medicine Pelvic Health Center, Seattle, Washington.
² Department of Urology, University of Washington School of Medicine, Seattle, Washington.

Comment

Suzette E Sutherland. J Urol. 2020 May.

. 2020 May;203(5):976.

doi: 10.1097/JU.0000000000000656.01. Epub 2020 Feb 11.

Suzette E Sutherland^{1

2}

¹ Female Urology, UW Medicine Pelvic Health Center, Seattle, Washington.
² Department of Urology, University of Washington School of Medicine, Seattle, Washington.

No abstract available

Comment in

Reply by Authors.
Harvie HS, Amundsen CL, Neuwahl SJ, Honeycutt AA, Lukacz ES, Sung VW, Rogers RG, Ellington D, Ferrando CA, Chermansky CJ, Mazloomdoost D, Thomas S. Harvie HS, et al. J Urol. 2020 May;203(5):977. doi: 10.1097/JU.0000000000000656.02. Epub 2020 Feb 11. J Urol. 2020. PMID: 32073947 Free PMC article. No abstract available.

Cost-Effectiveness of Sacral Neuromodulation versus OnabotulinumtoxinA for Refractory Urgency Urinary Incontinence: Results of the ROSETTA Randomized Trial.
Harvie HS, Amundsen CL, Neuwahl SJ, Honeycutt AA, Lukacz ES, Sung VW, Rogers RG, Ellington D, Ferrando CA, Chermansky CJ, Mazloomdoost D, Thomas S. Harvie HS, et al. J Urol. 2020 May;203(5):969-977. doi: 10.1097/JU.0000000000000656. Epub 2019 Nov 18. J Urol. 2020. PMID: 31738113 Free PMC article. Clinical Trial.